secwatch / observer

MEDICINOVA INC — fact timeline

Source-grounded facts extracted from MEDICINOVA INC's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.

MNOV MEDICINOVA INC JSON
Material Agreements

MEDICINOVA INC entered into Sales Agreement with Lucid Capital Markets, LLC valued at $50,000,000 (effective 2025-12-29).

“On December 29, 2025, MediciNova, Inc. (the “Company”) entered into an equity distribution agreement with Lucid Capital Markets, LLC (“Agent”) to sell shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), from time to time through the Agent, acting as sales agent, having a maximum aggregate offering price of $50,000,000 (the “Sales Agreement”).”

Geoffrey O'Brien resigned as Vice President at MEDICINOVA INC.

“On March 26, 2024, Geoffrey O’Brien informed MediciNova, Inc. (the “Company”) of his decision to retire from full-time employment and resign from his employment with the Company, effective as of April 2, 2024.”

Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.